Storia in 2 fonti

Emcure Pharmaceuticals Q1 profit rises 36% at ₹292.5 crore

Emcure Pharmaceuticals reports a 36% profit increase to ₹292.5 crore in Q1, driven by strong international business growth.

Raccontata da

thehindubusinessline.com

economictimes.indiatimes.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

thehindubusinessline.comStai leggendo1 g fa

Emcure Pharmaceuticals Q1 profit rises 36% at ₹292.5 crore

Emcure Pharmaceuticals reports a 36% profit increase to ₹292.5 crore in Q1, driven by strong international business growth.

originale

economictimes.indiatimes.com1 g fa

Emcure Pharma net profit up 36% at Rs 292 crore

Emcure Pharmaceuticals reported a 23% revenue increase in the first quarter. Ebitda grew 25.8% with improved margins, reflecting productivity gains. Net profit saw a significant 36.2% rise during the period. The company…

Leggi questa versione → originale

Timeline cronologica

giovedì 6 agosto 2026·thehindubusinessline.com
Emcure Pharmaceuticals Q1 profit rises 36% at ₹292.5 crore
Emcure Pharmaceuticals reports a 36% profit increase to ₹292.5 crore in Q1, driven by strong international business growth.
giovedì 6 agosto 2026·economictimes.indiatimes.com
Emcure Pharma Q1 profit jumps 36%, revenue rises 23%; appoints Samit Mehta as COO
"We have begun FY27, the second year of our five-year plan—on a strong footing. FY26 was about putting the building blocks in place across teams, portfolio, integration and…

Emcure Pharmaceuticals Q1 profit rises 36% at ₹292.5 crore

Emcure Pharma net profit up 36% at Rs 292 crore

Timeline cronologica

Emcure Pharmaceuticals Q1 profit rises 36% at ₹292.5 crore

Emcure Pharma Q1 profit jumps 36%, revenue rises 23%; appoints Samit Mehta as COO

Emcure Pharma net profit up 36% at Rs 292 crore